A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
Abstract The sodium-dependent glucose transporters 2 (SGLT2) plays important role in renal reabsorption of urinal glucose back to plasma for maintaining glucose homeostasis. The approval of SGLT2 inhibitors for treatment of type 2 diabetes highlights the SGLT2 as a feasible and promising drug target...
Main Authors: | Yan-Ting Lu, Xiu-Li Ma, Yu-Hui Xu, Jing Hu, Fang Wang, Wan-Ying Qin, Wen-Yong Xiong |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-11-01
|
Series: | Natural Products and Bioprospecting |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s13659-018-0188-4 |
Similar Items
-
A cell-based fluorescent glucose transporter assay for SGLT2 inhibitor discovery
by: Yi Huan, et al.
Published: (2013-04-01) -
SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2
by: Ying Zhou, et al.
Published: (2019-01-01) -
Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1
by: Alex Ali Sayour, et al.
Published: (2021-09-01) -
Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling
by: S. Kalra, et al.
Published: (2016-08-01) -
SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease
by: Swetha R. Kanduri, et al.
Published: (2020-08-01)